Abbott Laboratories (TSX:ABT)

Market Cap	289.90B
Revenue (ttm)	61.07B
Net Income (ttm)	19.40B
Shares Out	n/a
EPS (ttm)	11.09
PE Ratio	14.95
Forward PE	21.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	945
Average Volume	1,161
Open	20.00
Previous Close	21.46
Day's Range	19.07 - 20.00
52-Week Range	19.07 - 22.79
Beta	1.05
RSI	37.78
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Software - Application
• Sector: Technology
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD